Literature DB >> 25133031

Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature.

Patricia Sarlos1, Erzsebet Kovesdi1, Lili Magyari1, Zsolt Banfai1, Andras Szabo1, Andras Javorhazy1, Bela Melegh1.   

Abstract

Ulcerative colitis (UC) is one of the main types of inflammatory bowel disease, which is caused by dysregulated immune responses in genetically predisposed individuals. Several genetic factors, including interleukin and interleukin receptor gene polymorphisms and other inflammation-related genes play central role in mediating and modulating the inflammation in the human body, thereby these can be the main cause of development of the disease. It is clear these data are very important for understanding the base of the disease, especially in terms of clinical utility and validity, but summarized literature is exiguous for challenge health specialist that can used in the clinical practice nowadays. This review summarizes the current literature on inflammation-related genetic polymorphisms which are associated with UC. We performed an electronic search of Pubmed Database among publications of the last 10 years, using the following medical subject heading terms: UC, ulcerative colitis, inflammation, genes, polymorphisms, and susceptibility.

Entities:  

Keywords:  Genes; Inflammatory factors; Polymorphisms; Susceptibility; Ulcerative colitis

Year:  2014        PMID: 25133031      PMCID: PMC4133528          DOI: 10.4291/wjgp.v5.i3.304

Source DB:  PubMed          Journal:  World J Gastrointest Pathophysiol        ISSN: 2150-5330


  204 in total

1.  Replication and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3).

Authors:  B Dechairo; C Dimon; D van Heel; I Mackay; M Edwards; P Scambler; D Jewell; L Cardon; N Lench; A Carey
Journal:  Eur J Hum Genet       Date:  2001-08       Impact factor: 4.246

Review 2.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

3.  OCTN1 variant L503F is associated with familial and sporadic inflammatory bowel disease.

Authors:  Zhenwu Lin; Laurie Nelson; Andre Franke; Lisa Poritz; Tong-Yi Li; Rongling Wu; Yunhua Wang; Colin MacNeill; Neal J Thomas; Stefan Schreiber; Walter A Koltun
Journal:  J Crohns Colitis       Date:  2009-10-24       Impact factor: 9.071

4.  Role of STAT3 Locus in autoimmune diseases.

Authors:  M R Jabalameli
Journal:  Genes Immun       Date:  2011-01-06       Impact factor: 2.676

5.  Interleukin-17 is a potent immuno-modulator and regulator of normal human intestinal epithelial cell growth.

Authors:  S Schwartz; J F Beaulieu; F M Ruemmele
Journal:  Biochem Biophys Res Commun       Date:  2005-09-21       Impact factor: 3.575

6.  Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis.

Authors:  B Mulcahy; F Waldron-Lynch; M F McDermott; C Adams; C I Amos; D K Zhu; R H Ward; D O Clegg; F Shanahan; M G Molloy; F O'Gara
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

Review 7.  Janus kinases in immune cell signaling.

Authors:  Kamran Ghoreschi; Arian Laurence; John J O'Shea
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

8.  Readressing the role of Toll-like receptor-4 alleles in inflammatory bowel disease: colitis, smoking, and seroreactivity.

Authors:  Anastassios C Manolakis; Andreas N Kapsoritakis; Anastasia Kapsoritaki; Elisavet K Tiaka; Konstantinos A Oikonomou; Vassilis Lotis; Dimitra Vamvakopoulou; Ioanna Davidi; Nikolaos Vamvakopoulos; Spyros P Potamianos
Journal:  Dig Dis Sci       Date:  2012-08-24       Impact factor: 3.199

9.  Genetic polymorphisms of interleukin 8 and risk of ulcerative colitis in the Chinese population.

Authors:  Keshen Li; Songpo Yao; Shengyuan Liu; Binyou Wang; Dongwei Mao
Journal:  Clin Chim Acta       Date:  2009-04-05       Impact factor: 3.786

10.  CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium.

Authors:  L Piali; P Hammel; C Uherek; F Bachmann; R H Gisler; D Dunon; B A Imhof
Journal:  J Cell Biol       Date:  1995-07       Impact factor: 10.539

View more
  9 in total

1.  Downregulation of miR-214-3p May Contribute to Pathogenesis of Ulcerative Colitis via Targeting STAT6.

Authors:  Jin-An Li; Yong-Duo Wang; Kui Wang; Zhen-Lan Wang; Dao-Yong Jia; Bi-Ying Yang; Chang-Bing Xiong
Journal:  Biomed Res Int       Date:  2017-07-02       Impact factor: 3.411

2.  Feasibility of salivary DNA collection in a population-based case-control study: a pilot study of pediatric Crohn's disease.

Authors:  Michael D Kappelman; Aksel Lange; Rachel L Randell; Patricia V Basta; Robert S Sandler; Kristina Laugesen; Anna Byrjalsen; Tina Christensen; Trine Frøslev; Rune Erichsen
Journal:  Clin Epidemiol       Date:  2018-02-28       Impact factor: 4.790

3.  Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study.

Authors:  Satoshi Motoya; Kenji Watanabe; Haruhiko Ogata; Takanori Kanai; Toshiyuki Matsui; Yasuo Suzuki; Mitsuhiro Shikamura; Kenkichi Sugiura; Kazunori Oda; Tetsuharu Hori; Takahiro Araki; Mamoru Watanabe; Toshifumi Hibi
Journal:  PLoS One       Date:  2019-02-26       Impact factor: 3.240

4.  A Phase 1, Multiple-Dose Study of Vedolizumab in Japanese Patients With Ulcerative Colitis.

Authors:  Kiyonori Kobayashi; Yasuo Suzuki; Kenji Watanabe; Kazunori Oda; Miyuki Mukae; Akihiro Yamada; Hirokazu Yamagami; Akira Nishimura; Hiroyuki Okamoto
Journal:  J Clin Pharmacol       Date:  2018-09-07       Impact factor: 3.126

5.  Mechanisms of Paeonia lactiflora in Treatment of Ulcerative Colitis: A Network Pharmacological Study.

Authors:  Yin Zhang; Xiaoyan Li; Xianlin Xu; Ningxi Yang
Journal:  Med Sci Monit       Date:  2019-10-09

6.  Protective effect of Gloeostereum incarnatum on ulcerative colitis via modulation of Nrf2/NF‑κB signaling in C57BL/6 mice.

Authors:  Xiao Li; Xin Liu; Yongfeng Zhang; Yaqin Zhang; Shuyan Liu; Nan Zhang; Yu Li; Di Wang
Journal:  Mol Med Rep       Date:  2020-08-05       Impact factor: 2.952

7.  Evidence for the butyrate metabolism as key pathway improving ulcerative colitis in both pediatric and adult patients.

Authors:  Zheng Zhou; Jiasheng Cao; Xiaoming Liu; Mingsong Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  Detection of QTL controlling feed efficiency and excretion in chickens fed a wheat-based diet.

Authors:  Sandrine Mignon-Grasteau; Nicole Rideau; Irène Gabriel; Céline Chantry-Darmon; Marie-Yvonne Boscher; Nadine Sellier; Marie Chabault; Elisabeth Le Bihan-Duval; Agnès Narcy
Journal:  Genet Sel Evol       Date:  2015-09-25       Impact factor: 4.297

Review 9.  Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies.

Authors:  Amandip Kaur; Paraskevi Goggolidou
Journal:  J Inflamm (Lond)       Date:  2020-04-21       Impact factor: 4.981

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.